IL249336A0 - Methods for the preparation of heterocyclic compounds of 3,1-benzodioxole - Google Patents

Methods for the preparation of heterocyclic compounds of 3,1-benzodioxole

Info

Publication number
IL249336A0
IL249336A0 IL249336A IL24933616A IL249336A0 IL 249336 A0 IL249336 A0 IL 249336A0 IL 249336 A IL249336 A IL 249336A IL 24933616 A IL24933616 A IL 24933616A IL 249336 A0 IL249336 A0 IL 249336A0
Authority
IL
Israel
Prior art keywords
preparation
methods
heterocyclic compounds
benzodioxole
benzodioxole heterocyclic
Prior art date
Application number
IL249336A
Other languages
English (en)
Hebrew (he)
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL249336A0 publication Critical patent/IL249336A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL249336A 2014-06-23 2016-12-01 Methods for the preparation of heterocyclic compounds of 3,1-benzodioxole IL249336A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14173397 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (1)

Publication Number Publication Date
IL249336A0 true IL249336A0 (en) 2017-02-28

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249336A IL249336A0 (en) 2014-06-23 2016-12-01 Methods for the preparation of heterocyclic compounds of 3,1-benzodioxole

Country Status (18)

Country Link
US (1) US9908894B2 (enExample)
EP (1) EP3157930B1 (enExample)
JP (1) JP6785666B2 (enExample)
KR (1) KR20170016894A (enExample)
CN (1) CN106459081B (enExample)
AU (1) AU2015279428B2 (enExample)
BR (1) BR112016029510A2 (enExample)
CA (1) CA2953284A1 (enExample)
DK (1) DK3157930T3 (enExample)
ES (1) ES2702451T3 (enExample)
IL (1) IL249336A0 (enExample)
MX (1) MX2016016378A (enExample)
PL (1) PL3157930T3 (enExample)
PT (1) PT3157930T (enExample)
RU (1) RU2697251C2 (enExample)
TW (1) TW201613934A (enExample)
WO (1) WO2015197534A2 (enExample)
ZA (1) ZA201608442B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11370799B2 (en) 2015-12-18 2022-06-28 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
BR112019025028A2 (pt) 2017-06-20 2020-06-16 Leo Pharma A/S Método para preparar um composto.
JP7203846B2 (ja) 2017-12-15 2023-01-13 ユニオン・セラピューティクス・アクティエセルスカブ 置換アゼチジンジヒドロチエノピリジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
EP4282414A3 (en) 2019-01-15 2024-02-21 UNION therapeutics A/S Modified release tablet formulations containing phosphodiesterase inhibitors
MX2023011176A (es) 2021-03-22 2024-01-04 Union Therapeutics As Tratamiento de hidradenitis supurativa con orismilast.
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE69636086T2 (de) * 1995-05-19 2006-11-30 Kyowa Hakko Kogyo Co., Ltd. Sauerstoff enthaltende heterocyclische verbindungen
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
CA2491464A1 (en) * 2002-07-03 2004-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
DE602007012105D1 (de) * 2006-07-14 2011-03-03 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
WO2008077404A1 (en) * 2006-12-22 2008-07-03 Leo Pharma A/S Substituted acetophenones useful as pde4 inhibitors
CA2676933C (en) * 2007-02-28 2015-09-29 Leo Pharma A/S Novel phosphodiesterase inhibitors
CN101631792B (zh) * 2007-02-28 2013-05-01 利奥制药有限公司 新的磷酸二酯酶抑制剂
PT2585469T (pt) * 2010-06-24 2016-08-29 Leo Pharma As Compostos heterocíclicos de benzodioxolo ou benzodioxepina como inibidores da fosfodiesterase
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
US11370799B2 (en) * 2015-12-18 2022-06-28 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Also Published As

Publication number Publication date
AU2015279428A1 (en) 2017-01-05
WO2015197534A3 (en) 2016-03-17
EP3157930B1 (en) 2018-10-17
US9908894B2 (en) 2018-03-06
RU2697251C2 (ru) 2019-08-13
WO2015197534A2 (en) 2015-12-30
PT3157930T (pt) 2018-12-24
ZA201608442B (en) 2018-05-30
PL3157930T3 (pl) 2019-04-30
DK3157930T3 (en) 2019-01-21
KR20170016894A (ko) 2017-02-14
US20170137438A1 (en) 2017-05-18
AU2015279428B2 (en) 2018-02-15
ES2702451T3 (es) 2019-03-01
EP3157930A2 (en) 2017-04-26
RU2017101808A (ru) 2018-07-27
RU2017101808A3 (enExample) 2019-01-22
MX2016016378A (es) 2017-10-16
JP6785666B2 (ja) 2020-11-18
TW201613934A (en) 2016-04-16
JP2017520547A (ja) 2017-07-27
CN106459081B (zh) 2019-09-10
CN106459081A (zh) 2017-02-22
BR112016029510A2 (pt) 2017-08-22
CA2953284A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
ZA201605622B (en) 1,3-benzodioxole derivative
AP2016009297A0 (en) Novel heterocyclic compounds
IL247018A0 (en) Heterocyclic compound
IL248991B (en) Converted dihydroisoquinolinone compounds
ZA201700019B (en) Substituted [1,2,4]triazole compounds
IL285105A (en) Heterocyclic compound
IL259617B (en) Methods for the preparation of 3,1-benzodioxole heterocyclic compounds
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
ZA201608442B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
EP3110819A4 (en) Heterocyclic compounds
HUE036789T2 (hu) Szintéziseljárás 1,2-benzizotiazolin-3-on elõállítására
IL248267B (en) A process for preparing converted cycloserines
IL259556B1 (en) Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds
HUE049482T2 (hu) Új heterociklusos vegyület
IL260070B (en) A method for the preparation of converted 2-aryl-ethanols
GB2564185B (en) Process for the preparation of derivatives of benzodioxole
GB201501696D0 (en) Pharamaceutical Compounds
SG10201402964RA (en) Dehydration of 2,3-butanediole
GB201408238D0 (en) Synthesis of substituted 1,2,3-Triazoles